Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-202-6 | CAS number: 1313-13-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Epidemiological data
Administrative data
- Endpoint:
- epidemiological data
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Well reported and conducted to good scientific standards. Basis for classification of MnO2 as STOT RE 2.
Data source
Reference
- Reference Type:
- publication
- Title:
- Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust
- Author:
- Roels H A, Ghyselen P, Buchet JP, Ceulemans E & Lauwerys RR
- Year:
- 1 992
- Bibliographic source:
- British Journal of Industrial Medicine 1992; 49: 25-34
Materials and methods
- Study type:
- cohort study (prospective)
- Endpoint addressed:
- respiratory irritation
- neurotoxicity
Test guideline
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- Cohort study assessing neurofunctional effects of workers exposed to MnO2 in a dry alkaline battery factory and matched with controls in a factory with no exposure to manganese substances . The prevalence of neuropsychological and respiratory symptoms, lung ventilatory parameters, neurofunctional performances and several biological parameters were examined.
- GLP compliance:
- no
Test material
- Reference substance name:
- Manganese dioxide
- EC Number:
- 215-202-6
- EC Name:
- Manganese dioxide
- Cas Number:
- 1313-13-9
- Molecular formula:
- MnO2
- IUPAC Name:
- dioxomanganese
- Details on test material:
- - Name of test material (as cited in study report): MnO2 dust
Constituent 1
Method
- Type of population:
- occupational
- Ethical approval:
- not specified
- Details on study design:
- HYPOTHESIS TESTED (if cohort or case control study): Yes
METHOD OF DATA COLLECTION
- Type: Questionnaire, interview, clinical examination
- Details: Potential confounding factors related to hobby activities, previous employment, personal habits and medical history were controlled by questionnaire and interview. Clnical examination included: lung function tests, neurofunctional examination (visual reaction time, eye-hand coordination, hand steadiness, audioverbal short term memory), blood analyses, urine analyses
SETTING: Dry battery plant
STUDY POPULATION
- Total population (Total no. of persons in cohort from which the subjects were drawn): 92
- Selection criteria: No occupational exposure to mercury, lead, cadmium, solvents, or hazards interfering with lung function. Participants should not have suffered from lung disease and their medical history should not have shown any neurological or neuropsychiatric affections or current medical treatments that might influence the results of the neurofunctional tests.
- Total number of subjects participating in study: 193 ( included 101 in control group)
- Sex/age/race:, not stated, assumed male
- Smoker/non-smoker: 55% smoked in control and 48% smoked in exposed group.
- Matching criteria: Age, height, smoker, coffee-drinking, weight, work schedule, alcohol, education, salary
COMPARISON POPULATION
- Type: Other comparison group: Workers in a factory with no neurological confounders present
- Details: polymer-processing factory located in same area, same occupational physician with similar hiring criteria
HEALTH EFFECTS STUDIED
- Disease(s): neurofunctional effects, respiratory effects - Exposure assessment:
- measured
- Details on exposure:
- TYPE OF EXPOSURE: Inhalation
TYPE OF EXPOSURE MEASUREMENT: Personal sampling
EXPOSURE LEVELS: Respirable dust Geometric mean (GM) = 0.215 mg/m³; Total dust GM = 0.948 mg/m³
EXPOSURE PERIOD: Average of 5.3 years.
DESCRIPTION / DELINEATION OF EXPOSURE GROUPS / CATEGORIES: MnO2- exposed group and control group were young (mean age 30 yrs). Both groups were well-matched for age, height, weight, work schedule, coffee and alcohol consumption and smoking ( no statistically significant differences between exposed and control groups). A small difference in educational difference existed between the two groups (X² test, p = 0.046) due to a greater proportion of workers with a technical degree in the control plant. - Statistical methods:
- Statistical analyses were performed by SAS procedures.
Results and discussion
- Results:
- - Internal exposure to manganese
Manganese in blood (MnB): The MnB ranged from 0.25 to 1.31 µg/100 mL in the control group and from 0.21 to 2.10 µg/100 mL in the Mn exposed group.
Manganese in urine (MnU): The MnU ranged from 0.01 to 0.49 µg/g creatinine in the control group and from 0.15 to 7.33 µg/g creatinine in the exposed workers.
The geometric means of MnB and MnU were significantly higher in the Mn exposed group than in the control group
- Relation between parameters of external and internal exposure to manganese
On an individual basis, no statistically significant correlation was found between MnB or MnU and various external exposure parameters.
- Respiratory tract effects: No statistically significant differences
- Central nervous system effects: No statistically significant difference between control and exposed for neurovegetative complaints.
The MnO2-exposed workers performed several of the neurofunctional tests less well than the control group. The exposed group had significantly longer reaction times over the whole testing period than the control group. The five eye-hand coordination parameters indicated that the fine hand-forearm movement was more erratic in the MnO2-exposed workers than the control. The relevance of abnormal values for the five eye-hand coordination parameters were significantly higher in the Mn exposed group than in the control group. The results of the hole tremometer test showed a systematic tendency towards higher mean tremor scores in the Mn exposed group as compared with the control group. The prevalences of abnormal score values were also consistently higher in the Mn group than in the control group. Although the Mn workers performed less well in the audioverbal short term memory test than the control group, the mean scores of correctly recalled or recognised words were not significantly different between both groups. The abnormal performance in simple reaction time, eye-hand coordination, and hand steadiness increased with the cumulative integrated exposure (CEI) of respirable (MnRes) and total (MnTotal) measured by personal sampling
- Biological parameters: Al the haematological measurements were in the normal range both in the control and Mn exposed workers. The erythropoietic parameters (red blood cell count, haemoglobin, mean corpuscular volume, mean corpuscular haemoglobin concentration), and serum iron concentration, however, exhibited a consistent and statistically significant trend towards lower values in the Mn exposed workers.
- Dose response: The various neurofunctional effect variables and the variables of Mn exposure did not show clear cut dose-effect relations on an individual basis.
Applicant's summary and conclusion
- Conclusions:
- Manganese dioxide, in this study, caused statistically significant neurobehavioural differences in exposed workers, in the absence of confounding influences.
- Executive summary:
A cohort study, assessing neurofunctional effects of workers exposed to MnO2 in a dry alkaline battery factory and matched with controls in a factory with no exposure to manganese substances, was conducted. The prevalence of neuropsychological and respiratory symptoms, lung ventilatory parameters, neurofunctional performances and several biological parameters were examined.
Manganese dioxide, in this study, caused statistically significant neurobehavioural differences in exposed workers, in the absence of confounding influences.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.